- Filed
- Mar 10, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 3, 2025 | 19.76M sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 19.13M sh |
| Shares Diluted restated | FY 2024 · Dec 31, 2022 | 19.13M sh |
| Stock Repurchased | FY 2024 · Dec 31, 2023 | $239K |
| Capex | FY 2024 · Dec 31, 2023 | $10.63M |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | $2.53M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $11.29M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $24.97M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $25.26M |
| Current Assets | FY 2024 · Dec 31, 2023 | $118.82M |
| Total Assets | FY 2024 · Dec 31, 2023 | $172.63M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$0.81 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$0.81 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $18.9M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $9.4M |
| Net Income | FY 2024 · Dec 31, 2023 | −$15.42M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$17.35M |
| Revenue | FY 2024 · Dec 31, 2023 | $132.38M |
| Stockholders Equity restated | FY 2024 · Dec 31, 2022 | $158.44M |